Published date: 10 January 2022
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Vaccines - 33651600
Storage and warehousing services - 63120000
Health services - 85100000
Location of contract
Any region
Value of contract
£1 to £7,000,000
Procurement reference
20220110133650-68205
Published date
10 January 2022
Closing date
20 August 2021
Closing time
6pm
Contract start date
1 January 2022
Contract end date
31 December 2022
Contract type
Service contract
Procedure type
Open procedure
Any interested supplier may submit a tender in response to an opportunity notice.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
Yes
Description
On behalf of the NHS England and Improvement (the "Authority"), NHS Arden and GEM Commissioning Support Unit (AG CSU) invited suitably qualified, licensed and experienced service providers to submit their bids for providing warehousing and logistics services appropriate for the storage and handling of vaccines, which currently are expected to include Ultra-Low Temperature (ULT) materials and other associated materials.
The key objective of this procurement were to select a service provider(s) to provide:
• Safe, effective and appropriate storage/warehousing for vaccines, which will include for vaccines with Ultra Low Temperature handling characteristics and associated consumables
• Safe, effective and appropriate distribution of vaccines with varying handling characteristics and associated consumables materials to multiple designated delivery sites; and
• Appropriate equipment for the storage and distribution of vaccines and associated consumables. It should be noted that the Authority may provide FOC the ULT freezers
The Procurement is to award two contracts for a period of 12 months with the option to extend by two separate periods of up to 6-months each. The successful bidder(s) will be responsible for providing the Services across England whereby there will be a split of volume and activity on an East & West Split (with an extra split of the London region of 50/50).
The Authority is appointing 2 Providers for these Services. Whilst each Provider will be required to provide the Services on a national basis if required by the Authority, it is the Authority's intention that the Providers will provide Services on a regional split basis, with one Provider providing Services and delivering vaccines to the east of England with the other Provider providing Services and delivering vaccines to the west of England.
It should be noted that any service may be subject to variation during its term, which will be dictated by the emerging science and policy changes. Such variation may include but not be limited to:
• Approval of new vaccines that may require handling based on the individual vaccine handling characteristic or requirements for joint-vaccination with other vaccines
• Changes to the profile of eligible cohorts to receive the vaccine, which may increase/decrease the volume of vaccines to be handled and distributed and the designated sites to which deliveries will be required
• Increases in the type and number of and type of vaccine consumables
• Requirement for IT integration to the Successful Bidders systems to enable automation of vaccine orders by designated sites 'Pull delivery model' and include automated operation and performance reporting.
Award information
Awarded date
1 December 2021
Contract start date
1 January 2022
Contract end date
31 December 2022
Total value of contract
£5,200,000
This contract was awarded to 2 suppliers.
AAH Pharmaceuticals
Address
Centurion Park,
Centurion Way,
Wilnecote,
Tamworth
B77 5PZReference
None
Supplier is SME?
No
Supplier is VCSE?
No
Additional details
-
The actual volumes of vaccine and type is not yet fully known and therefore any volumes or costs estimates may change during the contract period. However, for the purpose of pricing the Authority provided an estimated value for the initial period of each contract at approximately £6.8M (excluding VAT) and was based on best estimated of volumes contain in the scenario in the ITT for the initial 12-month contract period.
NHS England and NHS Improvement will be the contracting and commissioning authority for the contract resultant from this procurement and the contract will be held between them and the successful bidder(s).
The successful provider commenced mobilisation from November 2021 and services were fully operational and providing services from December 2021.
Indicative contract value awarded to AAH Pharmaceuticals is £5200000.00
Alloga UK Limited
Address
Castlewood Business Park,
Farmwell Lane,
South Normanton
Derbyshire
DE55 2JXReference
None
Supplier is SME?
No
Supplier is VCSE?
No
Additional details
-
The actual volumes of vaccine and type is not yet fully known and therefore any volumes or costs estimates may change during the contract period. However, for the purpose of pricing the Authority provided an estimated value for the initial period of each contract at approximately £6.8M (excluding VAT) and was based on best estimated of volumes contain in the scenario in the ITT for the initial 12-month contract period.
NHS England and NHS Improvement will be the contracting and commissioning authority for the contract resultant from this procurement and the contract will be held between them and the successful bidder(s).
The successful provider commenced mobilisation from November 2021 and services were fully operational and providing services from December 2021.
Indicative contract value awarded to Alloga UK Limited is £4600000.00
About the buyer
Contact name
Warren Simms
Address
Quarry House
Leeds
LS2 7UE
ENG
Website
Share this notice
Closing: 20 August 2021, 6pm
All content is available under the
